Some Actionable Ideas in the Biotechnology and Pharmaceutical Sector: October 31 Sector Update
 Acadia Pharmaceuticals Inc (ACAD US), our portfolio company announced the initiation of a phase 2 study of Nuplazid in Alzheimer's related...
423 Views
Korea Stock Market Monthly Recap #7 - (October 2016)
The top events impacting the Korean stock market in October include the raid on Hanmi Pharm Co Ltd (128940 KS), disaster recall of Samsung...
317 Views
Pass on the Deal, Put on the Watchlist
This Insight finalizes our view of the listing of Samsung BioLogics (SB) using information presented at the company’s roadshow meeting and included...
356 Views
Key Drivers of Asia's Healthcare Sector
From a demand perspective, Asia’s population is growing as is longevity. On the supply side, Asia’s number of doctors, nurses, hospitals and...
3.5k Views
3 Main Debatable Points to Be Discussed in Samsung BioLogics NDR This Week
Samsung BioLogics is quite busy with NDR this week. BioLogics executives are doing their best to justify the proposed valuation for BioLogics IPO....
348 Views